Fingerprint Dive into the research topics of 'Effects of continued androgen-deprivation therapy and other prognostic factors on response and survival in phase II chemotherapy trials for hormone- refractory prostate cancer: A Southwest Oncology Group report'. Together they form a unique fingerprint.